Paclitaxel-resistant breast cancer tissue and cell line had downregulation of lncRNA which led to upregulation of miR-18b-5p and inhibited DOCK4 (Dedicator of cytokinesis protein 4) (Wang Y. Y. et al., 2019). The gene discussed is DOCK4; the disease is breast carcinoma.